These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 11113956)

  • 1. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.
    Barber JA; Thompson SG
    Stat Med; 2000 Dec; 19(23):3219-36. PubMed ID: 11113956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric modelling of cost data in medical studies.
    Nixon RM; Thompson SG
    Stat Med; 2004 Apr; 23(8):1311-31. PubMed ID: 15083485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.
    Briggs AH; Wonderling DE; Mooney CZ
    Health Econ; 1997; 6(4):327-40. PubMed ID: 9285227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-parametric methods for estimating confidence intervals around the incremental cost-effectiveness ratio].
    Petrinco M; Gregori D; Lazzarato F; Brunello F; Veltri A; Berchialla P; Pagano E
    Epidemiol Prev; 2008; 32(6):307-13. PubMed ID: 19353965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.
    Nixon RM; Wonderling D; Grieve RD
    Health Econ; 2010 Mar; 19(3):316-33. PubMed ID: 19378353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-parametric bootstrap confidence intervals for the intraclass correlation coefficient.
    Ukoumunne OC; Davison AC; Gulliford MC; Chinn S
    Stat Med; 2003 Dec; 22(24):3805-21. PubMed ID: 14673940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.
    Dwivedi AK; Mallawaarachchi I; Alvarado LA
    Stat Med; 2017 Jun; 36(14):2187-2205. PubMed ID: 28276584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36).
    Walters SJ; Campbell MJ
    Health Qual Life Outcomes; 2004 Dec; 2():70. PubMed ID: 15588308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The handling of uncertainty in economic evaluations of health care strategies].
    Siani C; Moatti JP
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):255-76. PubMed ID: 12876511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?
    O'Hagan A; Stevens JW
    Health Econ; 2003 Jan; 12(1):33-49. PubMed ID: 12483759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster randomized trials: another problem for cost-effectiveness ratios.
    Flynn TN; Peters TJ
    Int J Technol Assess Health Care; 2005; 21(3):403-9. PubMed ID: 16110722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials.
    Gomes M; Ng ES; Grieve R; Nixon R; Carpenter J; Thompson SG
    Med Decis Making; 2012; 32(2):350-61. PubMed ID: 22016450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining multiple imputation and bootstrap in the analysis of cost-effectiveness trial data.
    Brand J; van Buuren S; le Cessie S; van den Hout W
    Stat Med; 2019 Jan; 38(2):210-220. PubMed ID: 30207407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.
    Koch GG; Tangen CM; Jung JW; Amara IA
    Stat Med; 1998 Aug 15-30; 17(15-16):1863-92. PubMed ID: 9749453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
    Doshi JA; Glick HA; Polsky D
    Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confidence intervals for cost-effectiveness ratios: a comparison of four methods.
    Polsky D; Glick HA; Willke R; Schulman K
    Health Econ; 1997; 6(3):243-52. PubMed ID: 9226142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating external evidence in trial-based cost-effectiveness analyses: the use of resampling methods.
    Sadatsafavi M; Marra C; Aaron S; Bryan S
    Trials; 2014 Jun; 15():201. PubMed ID: 24888356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation.
    Briggs AH; Mooney CZ; Wonderling DE
    Stat Med; 1999 Dec; 18(23):3245-62. PubMed ID: 10602149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluations and randomized trials in spinal disorders: principles and methods.
    Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
    Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.